The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study
Publication
, Conference
Swords, RT; Erba, HP; DeAngelo, DJ; Smith, PG; Pickard, MD; Dezube, BJ; Giles, FJ; Medeiros, BC
Published in: BLOOD
November 19, 2010
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 19, 2010
Volume
116
Issue
21
Start / End Page
288 / 288
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Swords, R. T., Erba, H. P., DeAngelo, D. J., Smith, P. G., Pickard, M. D., Dezube, B. J., … Medeiros, B. C. (2010). The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study. In BLOOD (Vol. 116, pp. 288–288). Orlando, FL: AMER SOC HEMATOLOGY.
Swords, Ronan T., Harry P. Erba, Daniel J. DeAngelo, Peter G. Smith, Michael D. Pickard, Bruce J. Dezube, Francis J. Giles, and Bruno C. Medeiros. “The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study.” In BLOOD, 116:288–288. AMER SOC HEMATOLOGY, 2010.
Swords RT, Erba HP, DeAngelo DJ, Smith PG, Pickard MD, Dezube BJ, et al. The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study. In: BLOOD. AMER SOC HEMATOLOGY; 2010. p. 288–288.
Swords, Ronan T., et al. “The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study.” BLOOD, vol. 116, no. 21, AMER SOC HEMATOLOGY, 2010, pp. 288–288.
Swords RT, Erba HP, DeAngelo DJ, Smith PG, Pickard MD, Dezube BJ, Giles FJ, Medeiros BC. The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study. BLOOD. AMER SOC HEMATOLOGY; 2010. p. 288–288.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 19, 2010
Volume
116
Issue
21
Start / End Page
288 / 288
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology